Third week of April is Minority Cancer Awareness Week
“Let’s Achieve Health Equity”
Posted March 26, 2021
Gateway for Cancer Research℠ is investing up to $1.5 million to create a more diverse oncology workforce and expand clinical trial access for patients from underserved and minority communities. The Gateway Discovery Grant, administered by Conquer Cancer®, the ASCO Foundation, will provide funding to catalyze innovative clinical research with a strong potential impact on mitigating health...
Posted March 12, 2021
This session was developed to raise awareness about systemic racism in research and ensure that the field of hematology is positioned to conduct high-level, cutting-edge science driven by a diverse community. Dr. Mast opens this full-length recording of the session with a moving introduction that touches on his own personal experience coming to grips with bias as a White parent...
Posted March 3, 2021
Cancer affects each population differently, and minority groups in the United States bear a greater burden for many cancers. The Florida Society of Clinical Oncology is actively fighting cancer disparities on many fronts. On your cancer journey, you can do your part by making sure you, Just Ask. HELP US NARROW THE GAP!
Raez, Luis
Raez LE, Santos ES, Rolfo C, et al. Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America. Clin Lung Cancer. 2017;18(1):e71-e79.
Raez LE, Cardona AF, Santos ES, et al. The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. Lung Cancer. 2018;119:7-13.
Raez LE, Nogueira A, Santos ES, et al. Challenges in Lung Cancer Screening in Latin America. J Glob Oncol. 2018;4:1-10.
Pinto JA, Raez LE. Old myths about old patients: the case of non-small cell lung cancer. Transl Lung Cancer Res. 2018;7(Suppl 4):S362-S363.
Johnstone, Peter
Johnstone PA, Kane CJ, Sun L, et al. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology. 2002;225(2):420-426.
Beitinjaneh, Amer Morris
Wood WA, Brazauskas R, Hu ZH, et al. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. Biol Blood Marrow Transplant. 2018;24(9):1928-1935.
Blanquicett, Carmelo J
Blanquicett C, Cohen JB, Flowers C, Johnson T 2nd. The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient. Oncology (Williston Park). 2019;33(11):687524. Published 2019 Nov 14.
Farooqi, Bilal
Farooqi B, Smith B, Chowdhary M, Pavoni S, Modi A, Schnell F. Racial disparities in breast cancer diagnosis in Central Georgia in the United States. J Community Support Oncol. 2015;13(12):436-441.
Sanchez, Julian A
Schabath MB, Blackburn CA, Sutter ME, et al. National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer. J Clin Oncol. 2019;37(7):547-558.
Quinn GP, Sanchez JA, Sutton SK, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384-400.
Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers’ knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016;99(10):1676-1684.
Schabath MB, Curci MB, Kanetsky PA, et al. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017;13(8):542-546.
Ailawadhi, Sikander
Ganguly S, Mailankody S, Ailawadhi S. Many Shades of Disparities in Myeloma Care. Am Soc Clin Oncol Educ Book. 2019;39:519-529.
Ailawadhi S, Parikh K, Abouzaid S, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv. 2019;3(20):2986-2994.
Ailawadhi S, Jacobus S, Sexton R, et al. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials. Blood Cancer J. 2018;8(7):67.
Ailawadhi S, Frank RD, Sharma M, et al. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities. Cancer. 2018;124(8):1710-1721.
Rand KA, Song C, Dean E, et al. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev. 2016;25(12):1609-1618.
Ailawadhi S, Frank RD, Advani P, et al. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis. Cancer Med. 2017;6(12):2876-2885.
Ailawadhi S, Azzouqa AG, Hodge D, et al. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities. Clin Lymphoma Myeloma Leuk. 2019;19(10):619-623.
Nahleh, Zeina
Nahleh Z, Otoukesh S, Mirshahidi HR, et al. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med. 2018;7(6):2710-2717.
© 2020 FLASCO | Premium Website Design by The HDG
